Remove Clinical Trials Remove Collective Remove Epilepsy Remove Seminar
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

Then, looking for a better quality product, they contacted GW Pharmaceuticals — the British company that had licensed the cannabis collection of those globe-trotting 20th century cannabis collectors, Mr. Watson and Mr. Clarke, and which conducted the research in the ’90s that spurred Mr. Gardner’s CBD advocacy.

CBD 40
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Data collection. Conclusions. Palliative care indications. Cancer pain. Neuropathic pain. 2019 ; Sarris et al.